(2021). Bendamustine/ciclesonide/obinutuzumab: Diarrhoea following off-label use and prolonged viral shedding: case report. Reactions Weekly.
Chicago Style aipamena"Bendamustine/ciclesonide/obinutuzumab: Diarrhoea Following Off-label Use and Prolonged Viral Shedding: Case Report." Reactions Weekly 2021.
MLA aipamena"Bendamustine/ciclesonide/obinutuzumab: Diarrhoea Following Off-label Use and Prolonged Viral Shedding: Case Report." Reactions Weekly 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.